R0Z Stock Overview
Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Redsense Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.56 |
| 52 Week High | kr0.96 |
| 52 Week Low | kr0.38 |
| Beta | 0.55 |
| 1 Month Change | 20.34% |
| 3 Month Change | 33.81% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -27.39% |
Recent News & Updates
Recent updates
Shareholder Returns
| R0Z | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -9.4% | -0.5% | 2.0% |
| 1Y | n/a | -6.1% | 5.9% |
Return vs Industry: Insufficient data to determine how R0Z performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how R0Z performed against the German Market.
Price Volatility
| R0Z volatility | |
|---|---|
| R0Z Average Weekly Movement | 12.3% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: R0Z's share price has been volatile over the past 3 months.
Volatility Over Time: R0Z's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 5 | Pontus Nobreus | redsensemedical.com |
Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States. The company offers Redsense System, a medical technology product that is used for monitoring and alarming in the event of blood leakage in connection with a hemodialysis treatment. It also provides Redsense Clamp, which clamps the bloodline to stop blood flow when the alarm unit detects a blood leakage.
Redsense Medical AB (publ) Fundamentals Summary
| R0Z fundamental statistics | |
|---|---|
| Market cap | €8.25m |
| Earnings (TTM) | -€648.01k |
| Revenue (TTM) | €1.81m |
4.6x
P/S Ratio-12.7x
P/E RatioIs R0Z overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| R0Z income statement (TTM) | |
|---|---|
| Revenue | kr21.16m |
| Cost of Revenue | kr10.31m |
| Gross Profit | kr10.86m |
| Other Expenses | kr18.42m |
| Earnings | -kr7.57m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.54 |
| Gross Margin | 51.29% |
| Net Profit Margin | -35.75% |
| Debt/Equity Ratio | 0% |
How did R0Z perform over the long term?
See historical performance and comparison